Rankings
▼
Calendar
PLRX
Pliant Therapeutics, Inc.
$85M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$622,000
Operating Income
-$61M
Net Income
-$56M
EPS (Diluted)
$-0.92
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$47M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$484M
Total Liabilities
$91M
Stockholders' Equity
$393M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$248,000
-100.0%
Gross Profit
-$622,000
-$856,000
+27.3%
Operating Income
-$61M
-$47M
-28.1%
Net Income
-$56M
-$41M
-35.6%
← FY 2024
All Quarters
Q3 2024 →
PLRX Q2 2024 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena